Showing results (201-210 of 233) with videos related to
Sort By:
Pageof 24
Clinical Science (London, England : 1979)|December 1, 1979
Effect of captopril on renal vascular tone in patients with essential hypertensionA Mimran, H R Brunner, G A Turini, et al.Transactions - American Society for Artificial Internal Organs|January 1, 1976
The hypertension of long-term hemodialysis patients: studies with an angiotensin II antagonist (P113)A Mimran, S Shaldon, M N Mathieu, et al.European Journal of Gastroenterology & Hepatology|April 1, 1995
Cross hepatotoxicity between tricyclic antidepressants and phenothiazinesA J Remy, D Larrey, G P Pageaux, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1988
[Malignant arterial hypertension disclosing late congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency]J Ribstein, J P Sciolla, P Barjon, et al.The American Journal of Physiology|August 1, 1988
Renal ornithine decarboxylase activity, polyamines, and compensatory renal hypertrophy in the ratM H Humphreys, S B Etheredge, S Y Lin, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|February 24, 2001
[Microabluminuria in arterial hypertension. Measurement, variables, interpretation, recommendations]A Hornych, M Marre, A Mimran, et al.The American Journal of Physiology|December 1, 1994
Anatomic pairing of afferent arterioles and renin cell distribution in rat kidneysD Casellas, M Dupont, N Bouriquet, et al.Journal of Clinical Pharmacology|August 10, 2000
The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study GroupG L Bakris, P Whelton, M Weir, et al.Presse Medicale (Paris, France : 1983)|September 25, 2003
[Thyreotoxic periodic paralysis. A cause of pseudo-paralysing hypokalemia that should not be ignored in Caucasians]K Klouche, J Bismuth, C Lechiche, et al.La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|December 8, 1983
[Pseudo-hypercalcemia of erythrocytic origin. Increased passive membrane permeability to potassium]N Enet-Renou, J Mirouze, G Dagher, et al.Pageof 24